On 2025-05-15, Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) announced earnings per share of $-0.14 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.20.
The next expected annoucement date for quarterly earnings is 2025-08-20, with an average estimated earnings per share of $-0.20 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-15 | 2025-03-31 | $-0.20 | $-0.14 |
| 2025-03-03 | 2024-12-31 | $-0.20 | $-0.16 |
| 2024-11-14 | 2024-09-30 | $-0.20 | $-0.20 |
| 2024-08-21 | 2024-06-30 | $-0.20 | $-0.26 |
| 2024-05-09 | 2024-03-31 | $-0.20 | $-0.28 |
| 2024-03-07 | 2023-12-31 | $-0.40 | $-0.26 |
| 2023-11-09 | 2023-09-30 | $-0.60 | $-0.34 |
| 2023-08-14 | 2023-06-30 | $-0.80 | $-0.72 |
| 2023-05-11 | 2023-03-31 | $-0.80 | $-0.80 |
| 2023-03-20 | 2022-12-31 | $-0.80 | $-0.72 |
| 2022-11-11 | 2022-09-30 | $-0.60 | $-0.70 |
| 2022-08-12 | 2022-06-30 | $-0.60 | $-0.54 |
| 2022-05-12 | 2022-03-31 | $-0.40 | $-0.44 |
| 2022-03-09 | 2021-12-31 | $-0.40 | $-0.44 |
| 2021-11-12 | 2021-09-30 | $-0.02 | $-0.26 |
| 2021-08-13 | 2021-06-30 | $-0.02 | $-0.26 |
| 2021-05-13 | 2021-03-31 | $-0.43 | $-0.22 |
| 2021-03-09 | 2020-12-31 | $-8.00 | $-4.00 |
| 2020-11-16 | 2020-09-30 | $-7.20 | $-5.60 |
| 2020-08-14 | 2020-06-30 | $-8.80 | $-7.20 |
| 2020-05-07 | 2020-03-31 | $-8.80 | $-6.56 |
| 2020-03-17 | 2019-12-31 | $-2.08 | $31.84 |
| 2019-11-15 | 2019-09-30 | $-2.40 | $-36.16 |
| 2019-08-05 | 2019-06-30 | $-12.48 | $-4.00 |
| 2019-05-22 | 2019-03-31 | -- | $-56.00 |
| 2019-02-12 | 2018-09-30 | -- | $2.72 |